Caricamento...
Bortezomib a Safe Treatment for Patients with Multiple Myeloma and Cystic Fibrosis
INTRODUCTION: Bortezomib is a proteasome inhibitor that targets myeloma cell and its bone marrow microenvironment. Intravenous Bortezomib with or without dexamethasone, is effective and well tolerated in patients with relapsed/refractory multiple myeloma (MM). METHODS: We used Bortezomib without cor...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Università Cattolica del Sacro Cuore
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3375716/ https://ncbi.nlm.nih.gov/pubmed/22708050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2012.035 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|